Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Visiedocument SWAB biedt alternatieven voor carbapenems
nov 2022 | Antibioticaresistentie, Bacteriële infecties